PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-13.71%
Negative net income growth while CRK stands at 74564.00%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
17.57%
Some D&A expansion while CRK is negative at -0.51%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
80.68%
Lower deferred tax growth vs. CRK's 562.54%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
-720.43%
Negative yoy working capital usage while CRK is 111.69%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-162.94%
Both negative yoy, with CRK at -91.79%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-45.29%
Negative yoy CFO while CRK is 132.43%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
21.44%
CapEx growth well above CRK's 9.59%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-641.12%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-226.89%
We reduce yoy invests while CRK stands at 9.59%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-2582.77%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-61.20%
Both yoy lines negative, with CRK at -80.76%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
94.45%
Buyback growth of 94.45% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.